Digital health company manufacturing molecular allergy tests (microarray) and providing at-home or clinic-based testing with lab analysis and digital reports, aiming to make laboratory-grade allergy diagnostics affordable and integrate with healthcare providers.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €2.56 M | Nov, 2025 | seed |
Industries
Frequently Asked Questions
What industries does Self.co operate in?
Self.co operates in the following industries: digital health, medical diagnostics, biotech, healthcare.
How much total funding has Self.co raised?
Self.co has raised a total of $2,560,000.
Who are the investors in Self.co?
The investors in Self.co are: Iron Wolf Capital, Coinvest, NGL Ventures, Innovation Agency Lithuania.